“…However, as a result of reported adverse effects, it has been used with caution in the pediatric patient population. While the most severe adverse effects have been reported outside the skeletal system, purported skeletal adverse effects include osteopenia, bone mineral density changes (BMD) in the spine and proximal femur, enthesopathy, and premature epiphyseal closure [2][3][4][5][6]. The growing skeleton is more sensitive to agents effecting bone development, which may limit isotretinoin utilization [1].…”